Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Victoria Delgado , Jose Luis Zamorano , Davide Capodanno , et al Added: 1 year ago
In this video series, first presented at the ESC Congress 2022, held in Barcelona, Prof Ralph Stephan von Bardeleben, Prof Jose LuisZamorano, Dr Victoria Delgado, Prof DavideCapodanno and Dr SashaKoul discuss the diagnosis of low flow/low gradient aortic stenosis, which patients gain the most benefit from TAVI and how to avoid heart failure in aortic stenosis patients. Join this international… View more
Author(s): Benjamin H Freed , Lissa Sugeng , Kathleen Furlong , et al Added: 3 years ago
Aortic stenosis (AS) is the most common valvular disease in the western hemisphere. Currently, 4% of the North American population above 75 years of age has AS, and approximately 50% of patients with mild to moderate AS will progress to hemodynamically severe AS in their lifetime.1 The natural history of the disease, which is largely unchanged since its initial description by Braunwald and Ross… View more
Author(s): Kendra J Grubb , Suzanne J Baron Added: 1 year ago
Bringing surgery and interventional cardiology together, Dr Suzanne Baron (Lahey Health, US)and her team published a review article on “The Evolving Role of the Multidisciplinary Heart Team in Aortic Stenosis”, in a comprehensive special focus issue on the “Lifetime Management of Patients With Aortic Stenosis” edited by Dr Kendra Grubb (Emory Structural Heart and Valve Center, US). In this… View more
Author(s): John Forrest Added: 1 year ago
ACC.23/WCC - We are joined onsite by Dr John Forrest (Yale Valve Clinic, US) in this short video, who outlines the three-year outcomes of the Evolut Low-Risk Trial(Medtronic Cardiovascular) (NCT02701283). This study aimed to compare transcatheter aortic valve replacement (TAVR) using Medtronic's TAVR valve with surgical aortic valve replacement (SAVR) in over 2000 patients with aortic stenosis… View more
Added: 1 year ago
TCT 22 - Prof Helge Möllmann joins us to discuss the findings of a study that aimed to evaluate the procedural safety and device performance of Abbott's Portico™ TAVI Valve in patients with severe symptomatic degenerative aortic stenosis. Originally presented at TCT 22, The CONFIDENCE Registry involved over 1000 patients with NYHA Class ≥ II Aortic Stenosis who received transcatheter aortic… View more
Author(s): Miho Fukui , João L Cavalcante Added: 3 years ago
Degenerative calcific aortic stenosis (AS) is one of the most common valvular heart diseases, affecting >3% of those aged >65 years in the West.1 As a result of an aging population, the prevalence of AS is expected to increase. Severe AS causes chronic pressure overload of the left ventricle (LV), resulting in LV hypertrophy (LVH), diastolic dysfunction, an increase in the size of the left… View more